MDGL SG&A Expense Growth
Madrigal Pharmaceuticals Inc · SG&A Expense Growth
MDGL SG&A Expense Growth
Latest reported87.06%period ending
MDGL FY SG&A Growth (YoY) (0.00% → 87.06%)
Latest values, visible window
High-resolution chart · PNG
MDGL sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 87.0622% | |
| 302.2867% | |
| 124.6956% | |
| 28.9726% | |
| 70.6824% | |
| -3.4617% | |
| 51.2791% | |
| 95.1382% | |
| -17.4166% | |
| -30.6302% | |
| -14.9498% | |
| 0.2994% | |
| 34.4553% | |
| 1.0734% | |
| 0.8996% | |
| -9.5012% | |
| -14.184% | |
| -1.2857% | |
| 72.6873% | |
| -23.3265% | |
| 52.7699% | |
| 40.3345% | |
| 0% | |
| -100% | |
| 0% |